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Dear Minister,  
 
Re: TCDOs and ACMD position on methylphenidate-based NPS 
 
On 30 October 2014, the then Minister for Crime Prevention, Norman Baker, wrote to 
the Advisory Council on the Misuse of Drugs (ACMD) seeking its view on extending  
the period for which a temporary class drug order (TCDOs) can be made from 12 to 
24 months  The Council notes that any such change would require primary 
legislation.  
 
The ACMD has considered this matter and has not found a strong case in support of 
a general extension to 24 months. To date, we have completed all follow-up reports 
to TCDOs within a time to allow the legislative process for permanent control to be 
completed within the 12 month timeframe. This has been the case when we advised 
on methoxetamine (October 2012), benzofurans (November 2013) and NBoMe 
compounds (November 2013).  
 
Whilst the ACMD will always aim to provide advice in time, there may be exceptional 
cases (see below) where this is not possible and more time is needed to gather 
sufficient evidence of medical or social harms to inform its deliberations for further 
advice under an existing TCDO. It is the ACMD’s view that in such exceptional 
circumstances this would be better managed by the remaking of the existing TCDO 
prior to its expiry, for a further period of up to 12 months.  
 
The ACMD has taken this view in the context of its current deliberation of the 
methylphenidate-based NPS, which has proven to be such an exceptional case.  
 
 
 
Methylphenidate-based NPS 
 
The current TCDO for a number of methylphenidate-based substances will expire on 
26 June 2016. [1]  
 
The ACMD is not able to provide advice for full control under the Misuse of Drugs 
Act 1971 at this time. We would like to request a further 12 months There is 
evidence that the current TCDO has reduced the usage of methylphenidate-based 
NPS and we believe that TCDO action and TCDO related offences remain 
proportionate whilst we gather further evidence.  
 
Impact of the TCDO  
 
Since the introduction of this TCDO, Police Scotland has reported that in Edinburgh 
there has been a reduction in:  
 
• The rate of infections (Staphylococcus, Streptococcus and Hepatitis C);  
• Admissions to accident and emergency / toxicology for intravenous users;  
• Admissions to rehabilitation services for acute mental health issues ; 
• Needle discards in public spaces. [2]  
 
The ACMD further invoked a Drugs Early Warning System (DEWS) request on these 
compounds in November 2015, which did not show any conclusive evidence of 
widespread prevalence.  
 
Recommendations 
 
The ACMD makes the following recommendations to the Home Office:  
 
1. That the experience to date does not justify a general extension of the time 
period for which a TCDO can be made under section 2A of the Misuse of 
Drugs Act 1971.     
 
2. That there is a recognition that in exceptional cases, the ACMD may need 
more time to examine the evidence base on a substance(s) subject to a 
temporary class drug order (TCDO) prior to arriving at a final 
recommendation.  
 
3. In the case of methylphenidate-based NPS, that the current TCDO is remade 
for up to a further 12 month period at its expiry (26 June 2016).  
 
 
 
                                                 
[1]
 https://www.gov.uk/government/publications/methylphenidate-based-novel-psychoactive-substances-
temporary-class-drug-order-report  
[2]
 Presentation from Police Scotland to ACMD NPS Committee 
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